These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15573860)

  • 1. Epidemiological, clinical, diagnostic and therapeutic survey of 686 cases of brucellosis.
    Ayatollahi J
    Ann Saudi Med; 2004; 24(5):398-9. PubMed ID: 15573860
    [No Abstract]   [Full Text] [Related]  

  • 2. Selected epidemiological features of human brucellosis in Yazd, Islamic Republic of Iran: 1993-1998.
    Salari MH; Khalili MB; Hassanpour GR
    East Mediterr Health J; 2003; 9(5-6):1054-60. PubMed ID: 16450537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of brucellosis antibodies in blood donors in North Lebanon.
    Kalaajieh WK; Rima AC; Al Khodayry RM; Dennaoui MS
    Rev Epidemiol Sante Publique; 2001 Jun; 49(3):315-28. PubMed ID: 11561545
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroprevalence of Brucellosis among Clinically Suspected Human Cases Presenting at Health Facilities in Namibia from 2012 to 2017.
    Madzingira O; Fasina FO; Kalinda C; Van Heerden H
    Biomed Environ Sci; 2021 Mar; 34(3):232-235. PubMed ID: 33766220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of human brucellosis in patients from Sinaloa, Mexico, en 2006].
    López-Moreno HS; Fonseca-Najar JM; Osuna-Ramírez I; Rendón-Maldonado JG; Uribe-Beltrán Mde J; Hernández-Ramírez CV
    Salud Publica Mex; 2008; 50(4):274-5. PubMed ID: 18683335
    [No Abstract]   [Full Text] [Related]  

  • 6. Brucella endocarditis: a report from Iran.
    Esmailpour N; Borna S; Nejad MR; Badie SM; Badie BM; Hadadi A
    Trop Doct; 2010 Jan; 40(1):47-9. PubMed ID: 19850601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, complications and treatment outcome of childhood brucellosis in central Greece.
    Tsolia M; Drakonaki S; Messaritaki A; Farmakakis T; Kostaki M; Tsapra H; Karpathios T
    J Infect; 2002 May; 44(4):257-62. PubMed ID: 12099734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of laboratory diagnosis on brucellosis therapy.
    Al Dahouk S; Nöckler K
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):833-45. PubMed ID: 21810055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The seroprevalence of brucellosis among undiagnosed family members of brucellosis positive patients.
    Alim A; Oguzkaya-Artan M; Artan C
    Niger J Clin Pract; 2015; 18(5):620-5. PubMed ID: 26096240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brucellosis: epidemiological, clinical and therapeutic aspects-- 47 cases].
    Bouzouaia N; Kilani B; Ben Chaabane T; Zouiten F; Tiouiri H; Gastli M; Zribi A
    Tunis Med; 1991 Nov; 69(11):611-5. PubMed ID: 1808769
    [No Abstract]   [Full Text] [Related]  

  • 11. Brucella endocarditis.
    Delvecchio G; Fracassetti O; Lorenzi N
    Int J Cardiol; 1991 Nov; 33(2):328-9. PubMed ID: 1743797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobrucellosis: report of a rare disease in 20 Iranian patients referred to a tertiary hospital.
    Ranjbar M; Rezaiee AA; Hashemi SH; Mehdipour S
    East Mediterr Health J; 2009; 15(1):143-8. PubMed ID: 19469437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, diagnostic, clinical, and therapeutic aspects of Brucella bacteremia in children in southern Israel: a 7-year retrospective study (2005-2011).
    Fruchtman Y; Segev RW; Golan AA; Dalem Y; Tailakh MA; Novak V; Peled N; Craiu M; Leibovitz E
    Vector Borne Zoonotic Dis; 2015 Mar; 15(3):195-201. PubMed ID: 25793475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Brucella in an elderly population in mid-Anatolia, Turkey.
    Sümer H; Sümer Z; Alim A; Nur N; Ozdemir L
    J Health Popul Nutr; 2003 Jun; 21(2):158-61. PubMed ID: 13677443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological features of human brucellosis in central Iran, 2006-2011.
    Zeinalian Dastjerdi M; Fadaei Nobari R; Ramazanpour J
    Public Health; 2012 Dec; 126(12):1058-62. PubMed ID: 22884862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human brucellosis in Lebanon. Clinical features and therapeutic responses in 88 patients].
    Tohme A; Zein E; El Rassi B; Koussa S; Nasnas R
    J Med Liban; 2004; 52(3):149-55. PubMed ID: 16432972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human brucellosis in Northern Saudi Arabia.
    Fallatah SM; Oduloju AJ; Al-Dusari SN; Fakunle YM
    Saudi Med J; 2005 Oct; 26(10):1562-6. PubMed ID: 16228056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological, clinical, and laboratory features of brucellar meningitis.
    Hatami H; Hatami M; Soori H; Janbakhsh AR; Mansouri F
    Arch Iran Med; 2010 Nov; 13(6):486-91. PubMed ID: 21039003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucellosis screening and follow-up of seropositive asymptomatic subjects among household members of shepherds in China.
    Hu J; Zhang X; Yang H; Zhang S; Wang T; An S; Li M; Li F; Luo J; Hu F; Wang D; Ni S; Sheng J; Zhang C; Zhen Q
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1325-1328. PubMed ID: 33411171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
    Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
    Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.